Insects Spotted in IV Solutions Spur Recall

Baxter International is recalling 2 lots of intravenous solutions due to the presence of insects.

In each reported case, the insect was identified as a result of a customer compliant. Fortunately, the matter was identified prior to drug administration and no associated adverse events have been reported to Baxter.

The recall affects Lot Numbers P319921 and P327635 of Baxter’s 0.9% Sodium Chloride Injection 50 mL and 100 mL, which were distributed to customers and distributors throughout the United States between October 7, 2014, and July 14, 2015.

The company cautioned that injecting a product containing particulate matter in the absence of in-line filtration may result in blockage of blood vessels, which can lead to stroke, heart attack, or organ damage.

Recalled products should be returned to Baxter for credit, and unaffected lots are available for replacement.

Health care professionals and patients are encouraged to report adverse effects related to the use of these recalled products to the FDA’s MedWatch Adverse Event Reporting Program.